Published in Medical Devices and Surgical Technology Week, July 23rd, 2006
The companies anticipate that negotiations and planning for the extension of this agreement into a long-term relationship will be finalized after initial feasibility studies are completed.
"We are pleased to enter into this agreement with BioD because of their extensive experience in tissue product procurement and development," said Andrew J. Tofe, PhD, chief executive officer of CeraPedics. "BioD understands that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week